Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Usaite, I."'
Autor:
Wu, Y., Biswas, D., Usaite, I., Angelova, M., Boeing, S., Karasaki, T., Veeriah, S., Czyzewska-Khan, J., Morton, C., Joseph, M., Hessey, S., Reading, J., Georgiou, A., Al-Bakir, M., McGranahan, N., Jamal-Hanjani, M., Hackshaw, A., Quezada, S.A., Hayday, A.C., Swanton, C.
Murine tissues harbor signature γδ T cell compartments with profound yet differential impacts on carcinogenesis. Conversely, human tissue-resident γδ cells are less well defined. In the present study, we show that human lung tissues harbor a resi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=mdc______med::e6f187944f063f251c4ee4f9be78f675
http://edoc.mdc-berlin.de/23128/1/23128oa.pdf
http://edoc.mdc-berlin.de/23128/1/23128oa.pdf
Autor:
Usaite I; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Biswas D; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Bill Lyons Informatics Centre, University College London Cancer Institute, London, UK., Dijkstra K; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Department of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Watkins TB; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Pich O; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Puttick C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Angelova M; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Thakkar K; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Tumour Immunogenomics and Immunosurveillance Laboratory, University College London Cancer Institute, London, UK., Hiley C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; University College London Hospitals NHS Foundation Trust, London, UK., Birkbak N; Department of Molecular Medicine, Aarhus Universitet, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus Universitet, Aarhus, Denmark., Kok M; Division of Tumor Biology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Zaccaria S; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Computational Cancer Genomics Research Group, University College London Cancer Institute, London, UK., Wu Y; Department of Medical Oncology, Guy's and St. Thomas' NHS Foundation Trust, London, UK.; Peter Gorer Department of Immunobiology and Centre for Inflammation Biology and Cancer Immunology, King's College London, London, UK., Litchfield K; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK charles.swanton@crick.ac.uk n.kanu@ucl.ac.uk k.litchfield@ucl.ac.uk.; Tumour Immunogenomics and Immunosurveillance Laboratory, University College London Cancer Institute, London, UK., Swanton C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK charles.swanton@crick.ac.uk n.kanu@ucl.ac.uk k.litchfield@ucl.ac.uk.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Kanu N; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK charles.swanton@crick.ac.uk n.kanu@ucl.ac.uk k.litchfield@ucl.ac.uk.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2023 Nov; Vol. 11 (11).
Autor:
Wu Y; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. yin.wu@kcl.ac.uk.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK. yin.wu@kcl.ac.uk.; Peter Gorer Department of Immunobiology, School of Immunology & Microbial Sciences, King's College London, London, UK. yin.wu@kcl.ac.uk.; Immunosurveillance Laboratory, The Francis Crick Institute, London, UK. yin.wu@kcl.ac.uk., Biswas D; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Bill Lyons Informatics Centre, University College London Cancer Institute, London, UK., Usaite I; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Angelova M; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Boeing S; Bioinformatics & Biostatistics and Software Development & Machine Learning Team, The Francis Crick Institute, London, UK., Karasaki T; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Veeriah S; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Czyzewska-Khan J; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Morton C; Peter Gorer Department of Immunobiology, School of Immunology & Microbial Sciences, King's College London, London, UK., Joseph M; Peter Gorer Department of Immunobiology, School of Immunology & Microbial Sciences, King's College London, London, UK.; Immunosurveillance Laboratory, The Francis Crick Institute, London, UK., Hessey S; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Metastasis Lab, University College London Cancer Institute, London, UK., Reading J; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK., Georgiou A; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK., Al-Bakir M; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., McGranahan N; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, University College London Cancer Institute, London, UK., Jamal-Hanjani M; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Metastasis Lab, University College London Cancer Institute, London, UK., Hackshaw A; Cancer Research UK & University College London Cancer Trials Centre, University College London, London, UK., Quezada SA; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK., Hayday AC; Peter Gorer Department of Immunobiology, School of Immunology & Microbial Sciences, King's College London, London, UK. adrian.hayday@kcl.ac.uk.; Immunosurveillance Laboratory, The Francis Crick Institute, London, UK. adrian.hayday@kcl.ac.uk., Swanton C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. charles.swanton@crick.ac.uk.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK. charles.swanton@crick.ac.uk.
Publikováno v:
Nature cancer [Nat Cancer] 2022 Jun; Vol. 3 (6), pp. 696-709. Date of Electronic Publication: 2022 May 30.
Autor:
Li J; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York., Duran MA; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York., Dhanota N; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York., Chatila WK; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Tri-Institutional Program in Computational Biology and Medicine, Weill Cornell Medical College, New York, New York., Bettigole SE; Volastra Therapeutics Inc., New York, New York., Kwon J; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York., Sriram RK; Meyer Cancer Center, Weill Cornell Medicine, New York, New York., Humphries MP; Precision Medicine Centre of Excellence, Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, United Kingdom., Salto-Tellez M; Precision Medicine Centre of Excellence, Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, United Kingdom.; Medical Sciences Division, Department of Oncology, University of Oxford, Oxford, United Kingdom., James JA; Precision Medicine Centre of Excellence, Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, United Kingdom., Hanna MG; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York., Melms JC; Columbia Center for Translational Immunology, New York, New York.; Division of Hematology and Oncology, Columbia University Medical Center, New York, New York., Vallabhaneni S; Laboratory for Systems Pharmacology, Harvard Medical School, Boston, Massachusetts., Litchfield K; Cancer Evolution and Genome Instability Laboratory, Francis Crick Institute, London, United Kingdom., Usaite I; Cancer Evolution and Genome Instability Laboratory, Francis Crick Institute, London, United Kingdom., Biswas D; Cancer Evolution and Genome Instability Laboratory, Francis Crick Institute, London, United Kingdom., Bareja R; Englander Institute for Precision Medicine, Meyer Cancer Center, Weill Cornell Medicine, New York, New York., Li HW; Columbia Center for Translational Immunology, New York, New York., Martin ML; Englander Institute for Precision Medicine, Meyer Cancer Center, Weill Cornell Medicine, New York, New York., Dorsaint P; Englander Institute for Precision Medicine, Meyer Cancer Center, Weill Cornell Medicine, New York, New York., Cavallo JA; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York., Li P; Immunology Program, Memorial Sloan Kettering Cancer Center, New York, New York., Pauli C; Institute for Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland., Gottesdiener L; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., DiPardo BJ; Department of Surgery, University of California, Los Angeles, California., Hollmann TJ; Medical Sciences Division, Department of Oncology, University of Oxford, Oxford, United Kingdom., Merghoub T; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Medicine, Weill Cornell Medicine, New York, New York.; Ludwig Collaborative and Swim Across America Laboratory, Memorial Sloan Kettering Cancer Center, New York, New York.; Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, New York, New York., Wen HY; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York., Reis-Filho JS; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York., Riaz N; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York., Su SM; Volastra Therapeutics Inc., New York, New York., Kalbasi A; Department of Radiation Oncology, Jonsson Comprehensive Cancer Center, University of California, Los Angeles, California., Vasan N; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Medicine, Weill Cornell Medicine, New York, New York., Powell SN; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York., Wolchok JD; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Medicine, Weill Cornell Medicine, New York, New York.; Ludwig Collaborative and Swim Across America Laboratory, Memorial Sloan Kettering Cancer Center, New York, New York.; Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, New York, New York., Elemento O; Englander Institute for Precision Medicine, Meyer Cancer Center, Weill Cornell Medicine, New York, New York., Swanton C; Cancer Evolution and Genome Instability Laboratory, Francis Crick Institute, London, United Kingdom., Shoushtari AN; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Medicine, Weill Cornell Medicine, New York, New York., Parkes EE; Precision Medicine Centre of Excellence, Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, United Kingdom.; Medical Sciences Division, Department of Oncology, University of Oxford, Oxford, United Kingdom., Izar B; Columbia Center for Translational Immunology, New York, New York.; Division of Hematology and Oncology, Columbia University Medical Center, New York, New York., Bakhoum SF; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York. samuel.bakhoum@gmail.com.; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
Publikováno v:
Cancer discovery [Cancer Discov] 2021 May; Vol. 11 (5), pp. 1212-1227. Date of Electronic Publication: 2020 Dec 28.
Publikováno v:
Prikladnaia biokhimiia i mikrobiologiia [Prikl Biokhim Mikrobiol] 1980 May-Jun; Vol. 16 (3), pp. 327-30.